Global and Japan Neurostimulation and Neuromodulation Device Market Insights, Forecast to 2026

Publisher Name :
Date: 28-Oct-2020
No. of pages: 144
Inquire Before Buying

Neurostimulation and Neuromodulation Device market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Neurostimulation and Neuromodulation Device market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Segment by Type, the Neurostimulation and Neuromodulation Device market is segmented into

- Internal

- External

Segment by Application, the Neurostimulation and Neuromodulation Device market is segmented into

- Hospitals and clinics

- Ambulatory Surgery Center

Regional and Country-level Analysis

The Neurostimulation and Neuromodulation Device market is analysed and market size information is provided by regions (countries).

The key regions covered in the Neurostimulation and Neuromodulation Device market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.

The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Neurostimulation and Neuromodulation Device Market Share Analysis

Neurostimulation and Neuromodulation Device market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Neurostimulation and Neuromodulation Device business, the date to enter into the Neurostimulation and Neuromodulation Device market, Neurostimulation and Neuromodulation Device product introduction, recent developments, etc.

The major vendors covered:

- Axogen

- Baxter

- Boston Scientific

- Livanova

- Integra Lifesciences

- Medtronic

- Abbott Laboratories

- Stryker

- Polyganics

- Nuvectra

- Neuropace

- Orthomed

- Nevro

Global and Japan Neurostimulation and Neuromodulation Device Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Neurostimulation and Neuromodulation Device Product Introduction
1.2 Market Segments
1.3 Key Neurostimulation and Neuromodulation Device Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Neurostimulation and Neuromodulation Device Market Size Growth Rate by Type
1.4.2 Internal
1.4.3 External
1.5 Market by Application
1.5.1 Global Neurostimulation and Neuromodulation Device Market Size Growth Rate by Application
1.5.2 Hospitals and clinics
1.5.3 Ambulatory Surgery Center
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Neurostimulation and Neuromodulation Device Market Size, Estimates and Forecasts
2.1.1 Global Neurostimulation and Neuromodulation Device Revenue 2015-2026
2.1.2 Global Neurostimulation and Neuromodulation Device Sales 2015-2026
2.2 Global Neurostimulation and Neuromodulation Device, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Neurostimulation and Neuromodulation Device Historical Market Size by Region (2015-2020)
2.3.1 Global Neurostimulation and Neuromodulation Device Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Neurostimulation and Neuromodulation Device Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Neurostimulation and Neuromodulation Device Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Neurostimulation and Neuromodulation Device Sales Forecast by Region (2021-2026)
2.4.2 Global Neurostimulation and Neuromodulation Device Revenue Forecast by Region (2021-2026)
3 Global Neurostimulation and Neuromodulation Device Competitor Landscape by Players
3.1 Global Top Neurostimulation and Neuromodulation Device Sales by Manufacturers
3.1.1 Global Neurostimulation and Neuromodulation Device Sales by Manufacturers (2015-2020)
3.1.2 Global Neurostimulation and Neuromodulation Device Sales Market Share by Manufacturers (2015-2020)
3.2 Global Neurostimulation and Neuromodulation Device Manufacturers by Revenue
3.2.1 Global Neurostimulation and Neuromodulation Device Revenue by Manufacturers (2015-2020)
3.2.2 Global Neurostimulation and Neuromodulation Device Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Neurostimulation and Neuromodulation Device Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Neurostimulation and Neuromodulation Device Revenue in 2019
3.2.5 Global Neurostimulation and Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Neurostimulation and Neuromodulation Device Price by Manufacturers
3.4 Global Neurostimulation and Neuromodulation Device Manufacturing Base Distribution, Product Types
3.4.1 Neurostimulation and Neuromodulation Device Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Neurostimulation and Neuromodulation Device Product Type
3.4.3 Date of International Manufacturers Enter into Neurostimulation and Neuromodulation Device Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Neurostimulation and Neuromodulation Device Market Size by Type (2015-2020)
4.1.1 Global Neurostimulation and Neuromodulation Device Sales by Type (2015-2020)
4.1.2 Global Neurostimulation and Neuromodulation Device Revenue by Type (2015-2020)
4.1.3 Neurostimulation and Neuromodulation Device Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Neurostimulation and Neuromodulation Device Market Size Forecast by Type (2021-2026)
4.2.1 Global Neurostimulation and Neuromodulation Device Sales Forecast by Type (2021-2026)
4.2.2 Global Neurostimulation and Neuromodulation Device Revenue Forecast by Type (2021-2026)
4.2.3 Neurostimulation and Neuromodulation Device Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Neurostimulation and Neuromodulation Device Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Neurostimulation and Neuromodulation Device Market Size by Application (2015-2020)
5.1.1 Global Neurostimulation and Neuromodulation Device Sales by Application (2015-2020)
5.1.2 Global Neurostimulation and Neuromodulation Device Revenue by Application (2015-2020)
5.1.3 Neurostimulation and Neuromodulation Device Price by Application (2015-2020)
5.2 Neurostimulation and Neuromodulation Device Market Size Forecast by Application (2021-2026)
5.2.1 Global Neurostimulation and Neuromodulation Device Sales Forecast by Application (2021-2026)
5.2.2 Global Neurostimulation and Neuromodulation Device Revenue Forecast by Application (2021-2026)
5.2.3 Global Neurostimulation and Neuromodulation Device Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Neurostimulation and Neuromodulation Device Market Size YoY Growth 2015-2026
6.1.1 Japan Neurostimulation and Neuromodulation Device Sales YoY Growth 2015-2026
6.1.2 Japan Neurostimulation and Neuromodulation Device Revenue YoY Growth 2015-2026
6.1.3 Japan Neurostimulation and Neuromodulation Device Market Share in Global Market 2015-2026
6.2 Japan Neurostimulation and Neuromodulation Device Market Size by Players (International and Local Players)
6.2.1 Japan Top Neurostimulation and Neuromodulation Device Players by Sales (2015-2020)
6.2.2 Japan Top Neurostimulation and Neuromodulation Device Players by Revenue (2015-2020)
6.3 Japan Neurostimulation and Neuromodulation Device Historic Market Review by Type (2015-2020)
6.3.1 Japan Neurostimulation and Neuromodulation Device Sales Market Share by Type (2015-2020)
6.3.2 Japan Neurostimulation and Neuromodulation Device Revenue Market Share by Type (2015-2020)
6.3.3 Japan Neurostimulation and Neuromodulation Device Price by Type (2015-2020)
6.4 Japan Neurostimulation and Neuromodulation Device Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Neurostimulation and Neuromodulation Device Sales Forecast by Type (2021-2026)
6.4.2 Japan Neurostimulation and Neuromodulation Device Revenue Forecast by Type (2021-2026)
6.4.3 Japan Neurostimulation and Neuromodulation Device Price Forecast by Type (2021-2026)
6.5 Japan Neurostimulation and Neuromodulation Device Historic Market Review by Application (2015-2020)
6.5.1 Japan Neurostimulation and Neuromodulation Device Sales Market Share by Application (2015-2020)
6.5.2 Japan Neurostimulation and Neuromodulation Device Revenue Market Share by Application (2015-2020)
6.5.3 Japan Neurostimulation and Neuromodulation Device Price by Application (2015-2020)
6.6 Japan Neurostimulation and Neuromodulation Device Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Neurostimulation and Neuromodulation Device Sales Forecast by Application (2021-2026)
6.6.2 Japan Neurostimulation and Neuromodulation Device Revenue Forecast by Application (2021-2026)
6.6.3 Japan Neurostimulation and Neuromodulation Device Price Forecast by Application (2021-2026)
7 North America
7.1 North America Neurostimulation and Neuromodulation Device Market Size YoY Growth 2015-2026
7.2 North America Neurostimulation and Neuromodulation Device Market Facts & Figures by Country
7.2.1 North America Neurostimulation and Neuromodulation Device Sales by Country (2015-2020)
7.2.2 North America Neurostimulation and Neuromodulation Device Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Neurostimulation and Neuromodulation Device Market Size YoY Growth 2015-2026
8.2 Europe Neurostimulation and Neuromodulation Device Market Facts & Figures by Country
8.2.1 Europe Neurostimulation and Neuromodulation Device Sales by Country
8.2.2 Europe Neurostimulation and Neuromodulation Device Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Neurostimulation and Neuromodulation Device Market Size YoY Growth 2015-2026
9.2 Asia Pacific Neurostimulation and Neuromodulation Device Market Facts & Figures by Country
9.2.1 Asia Pacific Neurostimulation and Neuromodulation Device Sales by Region (2015-2020)
9.2.2 Asia Pacific Neurostimulation and Neuromodulation Device Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Neurostimulation and Neuromodulation Device Market Size YoY Growth 2015-2026
10.2 Latin America Neurostimulation and Neuromodulation Device Market Facts & Figures by Country
10.2.1 Latin America Neurostimulation and Neuromodulation Device Sales by Country
10.2.2 Latin America Neurostimulation and Neuromodulation Device Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Neurostimulation and Neuromodulation Device Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Neurostimulation and Neuromodulation Device Market Facts & Figures by Country
11.2.1 Middle East and Africa Neurostimulation and Neuromodulation Device Sales by Country
11.2.2 Middle East and Africa Neurostimulation and Neuromodulation Device Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Axogen
12.1.1 Axogen Corporation Information
12.1.2 Axogen Description and Business Overview
12.1.3 Axogen Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Axogen Neurostimulation and Neuromodulation Device Products Offered
12.1.5 Axogen Recent Development
12.2 Baxter
12.2.1 Baxter Corporation Information
12.2.2 Baxter Description and Business Overview
12.2.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Baxter Neurostimulation and Neuromodulation Device Products Offered
12.2.5 Baxter Recent Development
12.3 Boston Scientific
12.3.1 Boston Scientific Corporation Information
12.3.2 Boston Scientific Description and Business Overview
12.3.3 Boston Scientific Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Boston Scientific Neurostimulation and Neuromodulation Device Products Offered
12.3.5 Boston Scientific Recent Development
12.4 Livanova
12.4.1 Livanova Corporation Information
12.4.2 Livanova Description and Business Overview
12.4.3 Livanova Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Livanova Neurostimulation and Neuromodulation Device Products Offered
12.4.5 Livanova Recent Development
12.5 Integra Lifesciences
12.5.1 Integra Lifesciences Corporation Information
12.5.2 Integra Lifesciences Description and Business Overview
12.5.3 Integra Lifesciences Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Integra Lifesciences Neurostimulation and Neuromodulation Device Products Offered
12.5.5 Integra Lifesciences Recent Development
12.6 Medtronic
12.6.1 Medtronic Corporation Information
12.6.2 Medtronic Description and Business Overview
12.6.3 Medtronic Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Medtronic Neurostimulation and Neuromodulation Device Products Offered
12.6.5 Medtronic Recent Development
12.7 Abbott Laboratories
12.7.1 Abbott Laboratories Corporation Information
12.7.2 Abbott Laboratories Description and Business Overview
12.7.3 Abbott Laboratories Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Abbott Laboratories Neurostimulation and Neuromodulation Device Products Offered
12.7.5 Abbott Laboratories Recent Development
12.8 Stryker
12.8.1 Stryker Corporation Information
12.8.2 Stryker Description and Business Overview
12.8.3 Stryker Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Stryker Neurostimulation and Neuromodulation Device Products Offered
12.8.5 Stryker Recent Development
12.9 Polyganics
12.9.1 Polyganics Corporation Information
12.9.2 Polyganics Description and Business Overview
12.9.3 Polyganics Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Polyganics Neurostimulation and Neuromodulation Device Products Offered
12.9.5 Polyganics Recent Development
12.10 Nuvectra
12.10.1 Nuvectra Corporation Information
12.10.2 Nuvectra Description and Business Overview
12.10.3 Nuvectra Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Nuvectra Neurostimulation and Neuromodulation Device Products Offered
12.10.5 Nuvectra Recent Development
12.11 Axogen
12.11.1 Axogen Corporation Information
12.11.2 Axogen Description and Business Overview
12.11.3 Axogen Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Axogen Neurostimulation and Neuromodulation Device Products Offered
12.11.5 Axogen Recent Development
12.12 Orthomed
12.12.1 Orthomed Corporation Information
12.12.2 Orthomed Description and Business Overview
12.12.3 Orthomed Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Orthomed Products Offered
12.12.5 Orthomed Recent Development
12.13 Nevro
12.13.1 Nevro Corporation Information
12.13.2 Nevro Description and Business Overview
12.13.3 Nevro Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Nevro Products Offered
12.13.5 Nevro Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Neurostimulation and Neuromodulation Device Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Neurostimulation and Neuromodulation Device Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Neurostimulation and Neuromodulation Device Market Segments
Table 2. Ranking of Global Top Neurostimulation and Neuromodulation Device Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Neurostimulation and Neuromodulation Device Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Internal
Table 5. Major Manufacturers of External
Table 6. Global Neurostimulation and Neuromodulation Device Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Neurostimulation and Neuromodulation Device Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Neurostimulation and Neuromodulation Device Sales by Regions 2015-2020 (K Units)
Table 9. Global Neurostimulation and Neuromodulation Device Sales Market Share by Regions (2015-2020)
Table 10. Global Neurostimulation and Neuromodulation Device Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Neurostimulation and Neuromodulation Device Sales Forecast by Region (2021-2026) (K Units)
Table 12. Global Neurostimulation and Neuromodulation Device Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Neurostimulation and Neuromodulation Device Sales Share by Manufacturers (2015-2020)
Table 14. Global Neurostimulation and Neuromodulation Device Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Neurostimulation and Neuromodulation Device by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Neurostimulation and Neuromodulation Device as of 2019)
Table 16. Neurostimulation and Neuromodulation Device Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Neurostimulation and Neuromodulation Device Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Neurostimulation and Neuromodulation Device Price (2015-2020) (USD/Unit)
Table 19. Neurostimulation and Neuromodulation Device Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Neurostimulation and Neuromodulation Device Product Type
Table 21. Date of International Manufacturers Enter into Neurostimulation and Neuromodulation Device Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Neurostimulation and Neuromodulation Device Sales by Type (2015-2020) (K Units)
Table 24. Global Neurostimulation and Neuromodulation Device Sales Share by Type (2015-2020)
Table 25. Global Neurostimulation and Neuromodulation Device Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Neurostimulation and Neuromodulation Device Revenue Share by Type (2015-2020)
Table 27. Neurostimulation and Neuromodulation Device Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Neurostimulation and Neuromodulation Device Sales Share by Type (2021-2026)
Table 29. Global Neurostimulation and Neuromodulation Device Sales by Application (2015-2020) (K Units)
Table 30. Global Neurostimulation and Neuromodulation Device Sales Share by Application (2015-2020)
Table 31. Global Neurostimulation and Neuromodulation Device Sales Share by Application (2021-2026)
Table 32. Global Neurostimulation and Neuromodulation Device Sales Market Share Forecast by Application (2021-2026)
Table 33. Global Neurostimulation and Neuromodulation Device Revenue by Application (2015-2020) (US$ Million)
Table 34. Global Neurostimulation and Neuromodulation Device Revenue Market Share Forecast by Application (2021-2026)
Table 35. Japan Neurostimulation and Neuromodulation Device Sales (K Units) of Key Companies (2015-2020)
Table 36. Japan Neurostimulation and Neuromodulation Device Sales Share by Company (2015-2020)
Table 37. Japan Neurostimulation and Neuromodulation Device Revenue (US$ Million) by Company (2015-2020)
Table 38. Japan Neurostimulation and Neuromodulation Device Sales (K Units) by Type (2015-2020)
Table 39. Japan Neurostimulation and Neuromodulation Device Sales Share by Type (2015-2020)
Table 40. Japan Neurostimulation and Neuromodulation Device Revenue (US$ Million) Market Share by Type (2015-2020)
Table 41. Japan Neurostimulation and Neuromodulation Device Price (K Units) by Type (2015-2020)
Table 42. Japan Neurostimulation and Neuromodulation Device Sales (K Units) by Type (2021-2026)
Table 43. Japan Neurostimulation and Neuromodulation Device Sales Share by Type (2021-2026)
Table 44. Japan Neurostimulation and Neuromodulation Device Revenue (US$ Million) Market Share by Type (2021-2026)
Table 45. Japan Neurostimulation and Neuromodulation Device Revenue Share by Type (2021-2026)
Table 46. Japan Neurostimulation and Neuromodulation Device Price (K Units) by Type (2021-2026)
Table 47. Japan Neurostimulation and Neuromodulation Device Sales (K Units) by Application (2015-2020)
Table 48. Japan Neurostimulation and Neuromodulation Device Sales Share by Application (2015-2020)
Table 49. Japan Neurostimulation and Neuromodulation Device Revenue (US$ Million) Market Share by Application (2015-2020)
Table 50. Japan Neurostimulation and Neuromodulation Device Sales (K Units) by Application (2021-2026)
Table 51. Japan Neurostimulation and Neuromodulation Device Sales Share by Application (2021-2026)
Table 52. Japan Neurostimulation and Neuromodulation Device Revenue (US$ Million) Market Share by Application (2021-2026)
Table 53. Japan Neurostimulation and Neuromodulation Device Revenue Share by Application (2021-2026)
Table 54. North America Neurostimulation and Neuromodulation Device Sales by Country (2015-2020) (K Units)
Table 55. North America Neurostimulation and Neuromodulation Device Sales Market Share by Country (2015-2020)
Table 56. North America Neurostimulation and Neuromodulation Device Revenue by Country (2015-2020) (US$ Million)
Table 57. North America Neurostimulation and Neuromodulation Device Revenue Market Share by Country (2015-2020)
Table 58. Europe Neurostimulation and Neuromodulation Device Sales by Country (2015-2020) (K Units)
Table 59. Europe Neurostimulation and Neuromodulation Device Sales Market Share by Country (2015-2020)
Table 60. Europe Neurostimulation and Neuromodulation Device Revenue by Country (2015-2020) (US$ Million)
Table 61. Europe Neurostimulation and Neuromodulation Device Revenue Market Share by Country (2015-2020)
Table 62. Asia Pacific Neurostimulation and Neuromodulation Device Sales by Region (2015-2020) (K Units)
Table 63. Asia Pacific Neurostimulation and Neuromodulation Device Sales Market Share by Region (2015-2020)
Table 64. Asia Pacific Neurostimulation and Neuromodulation Device Revenue by Region (2015-2020) (US$ Million)
Table 65. Asia Pacific Neurostimulation and Neuromodulation Device Revenue Market Share by Region (2015-2020)
Table 66. Latin America Neurostimulation and Neuromodulation Device Sales by Country (2015-2020) (K Units)
Table 67. Latin America Neurostimulation and Neuromodulation Device Sales Market Share by Country (2015-2020)
Table 68. Latin Americaa Neurostimulation and Neuromodulation Device Revenue by Country (2015-2020) (US$ Million)
Table 69. Latin America Neurostimulation and Neuromodulation Device Revenue Market Share by Country (2015-2020)
Table 70. Middle East and Africa Neurostimulation and Neuromodulation Device Sales by Country (2015-2020) (K Units)
Table 71. Middle East and Africa Neurostimulation and Neuromodulation Device Sales Market Share by Country (2015-2020)
Table 72. Middle East and Africa Neurostimulation and Neuromodulation Device Revenue by Country (2015-2020) (US$ Million)
Table 73. Middle East and Africa Neurostimulation and Neuromodulation Device Revenue Market Share by Country (2015-2020)
Table 74. Axogen Corporation Information
Table 75. Axogen Description and Business Overview
Table 76. Axogen Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 77. Axogen Neurostimulation and Neuromodulation Device Product
Table 78. Axogen Recent Development
Table 79. Baxter Corporation Information
Table 80. Baxter Description and Business Overview
Table 81. Baxter Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Baxter Product
Table 83. Baxter Recent Development
Table 84. Boston Scientific Corporation Information
Table 85. Boston Scientific Description and Business Overview
Table 86. Boston Scientific Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 87. Boston Scientific Product
Table 88. Boston Scientific Recent Development
Table 89. Livanova Corporation Information
Table 90. Livanova Description and Business Overview
Table 91. Livanova Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 92. Livanova Product
Table 93. Livanova Recent Development
Table 94. Integra Lifesciences Corporation Information
Table 95. Integra Lifesciences Description and Business Overview
Table 96. Integra Lifesciences Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 97. Integra Lifesciences Product
Table 98. Integra Lifesciences Recent Development
Table 99. Medtronic Corporation Information
Table 100. Medtronic Description and Business Overview
Table 101. Medtronic Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 102. Medtronic Product
Table 103. Medtronic Recent Development
Table 104. Abbott Laboratories Corporation Information
Table 105. Abbott Laboratories Description and Business Overview
Table 106. Abbott Laboratories Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 107. Abbott Laboratories Product
Table 108. Abbott Laboratories Recent Development
Table 109. Stryker Corporation Information
Table 110. Stryker Description and Business Overview
Table 111. Stryker Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Stryker Product
Table 113. Stryker Recent Development
Table 114. Polyganics Corporation Information
Table 115. Polyganics Description and Business Overview
Table 116. Polyganics Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Polyganics Product
Table 118. Polyganics Recent Development
Table 119. Nuvectra Corporation Information
Table 120. Nuvectra Description and Business Overview
Table 121. Nuvectra Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Nuvectra Product
Table 123. Nuvectra Recent Development
Table 124. Neuropace Corporation Information
Table 125. Neuropace Description and Business Overview
Table 126. Neuropace Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 127. Neuropace Product
Table 128. Neuropace Recent Development
Table 129. Orthomed Corporation Information
Table 130. Orthomed Description and Business Overview
Table 131. Orthomed Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 132. Orthomed Product
Table 133. Orthomed Recent Development
Table 134. Nevro Corporation Information
Table 135. Nevro Description and Business Overview
Table 136. Nevro Neurostimulation and Neuromodulation Device Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 137. Nevro Product
Table 138. Nevro Recent Development
Table 139. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 140. Key Challenges
Table 141. Market Risks
Table 142. Main Points Interviewed from Key Neurostimulation and Neuromodulation Device Players
Table 143. Neurostimulation and Neuromodulation Device Customers List
Table 144. Neurostimulation and Neuromodulation Device Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Neurostimulation and Neuromodulation Device Product Picture
Figure 2. Global Neurostimulation and Neuromodulation Device Sales Market Share by Type in 2020 & 2026
Figure 3. Internal Product Picture
Figure 4. External Product Picture
Figure 5. Global Neurostimulation and Neuromodulation Device Sales Market Share by Application in 2020 & 2026
Figure 6. Hospitals and clinics
Figure 7. Ambulatory Surgery Center
Figure 8. Neurostimulation and Neuromodulation Device Report Years Considered
Figure 9. Global Neurostimulation and Neuromodulation Device Market Size 2015-2026 (US$ Million)
Figure 10. Global Neurostimulation and Neuromodulation Device Sales 2015-2026 (K Units)
Figure 11. Global Neurostimulation and Neuromodulation Device Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Neurostimulation and Neuromodulation Device Sales Market Share by Region (2015-2020)
Figure 13. Global Neurostimulation and Neuromodulation Device Sales Market Share by Region in 2019
Figure 14. Global Neurostimulation and Neuromodulation Device Revenue Market Share by Region (2015-2020)
Figure 15. Global Neurostimulation and Neuromodulation Device Revenue Market Share by Region in 2019
Figure 16. Global Neurostimulation and Neuromodulation Device Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Neurostimulation and Neuromodulation Device Revenue in 2019
Figure 18. Neurostimulation and Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Neurostimulation and Neuromodulation Device Sales Market Share by Type (2015-2020)
Figure 20. Global Neurostimulation and Neuromodulation Device Sales Market Share by Type in 2019
Figure 21. Global Neurostimulation and Neuromodulation Device Revenue Market Share by Type (2015-2020)
Figure 22. Global Neurostimulation and Neuromodulation Device Revenue Market Share by Type in 2019
Figure 23. Global Neurostimulation and Neuromodulation Device Market Share by Price Range (2015-2020)
Figure 24. Global Neurostimulation and Neuromodulation Device Sales Market Share by Application (2015-2020)
Figure 25. Global Neurostimulation and Neuromodulation Device Sales Market Share by Application in 2019
Figure 26. Global Neurostimulation and Neuromodulation Device Revenue Market Share by Application (2015-2020)
Figure 27. Global Neurostimulation and Neuromodulation Device Revenue Market Share by Application in 2019
Figure 28. Japan Neurostimulation and Neuromodulation Device Sales Growth Rate 2015-2026 (K Units)
Figure 29. Japan Neurostimulation and Neuromodulation Device Revenue Growth Rate 2015-2026 (US$ Million)
Figure 30. Japan Neurostimulation and Neuromodulation Device Market Share in Global Market 2015-2026
Figure 31. Japan 5 and 10 Largest Neurostimulation and Neuromodulation Device Players Market Share by Revenue in Neurostimulation and Neuromodulation Device in 2019
Figure 32. Japan Neurostimulation and Neuromodulation Device Revenue Share by Type (2015-2020)
Figure 33. Japan Neurostimulation and Neuromodulation Device Revenue Growth Rate by Type in 2015 & 2019
Figure 34. Japan Neurostimulation and Neuromodulation Device Revenue Share by Application (2015-2020)
Figure 35. Japan Neurostimulation and Neuromodulation Device Revenue Growth Rate by Application in 2015 & 2019
Figure 36. North America Neurostimulation and Neuromodulation Device Sales Growth Rate 2015-2020 (K Units)
Figure 37. North America Neurostimulation and Neuromodulation Device Revenue Growth Rate 2015-2020 (US$ Million)
Figure 38. North America Neurostimulation and Neuromodulation Device Sales Market Share by Country in 2019
Figure 39. North America Neurostimulation and Neuromodulation Device Revenue Market Share by Country in 2019
Figure 40. U.S. Neurostimulation and Neuromodulation Device Sales Growth Rate (2015-2020) (K Units)
Figure 41. U.S. Neurostimulation and Neuromodulation Device Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Canada Neurostimulation and Neuromodulation Device Sales Growth Rate (2015-2020) (K Units)
Figure 43. Canada Neurostimulation and Neuromodulation Device Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. Europe Neurostimulation and Neuromodulation Device Sales Growth Rate 2015-2020 (K Units)
Figure 45. Europe Neurostimulation and Neuromodulation Device Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Neurostimulation and Neuromodulation Device Sales Market Share by Country in 2019
Figure 47. Europe Neurostimulation and Neuromodulation Device Revenue Market Share by Country in 2019
Figure 48. Germany Neurostimulation and Neuromodulation Device Sales Growth Rate (2015-2020) (K Units)
Figure 49. Germany Neurostimulation and Neuromodulation Device Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Neurostimulation and Neuromodulation Device Sales Growth Rate (2015-2020) (K Units)
Figure 51. France Neurostimulation and Neuromodulation Device Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Neurostimulation and Neuromodulation Device Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.K. Neurostimulation and Neuromodulation Device Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Neurostimulation and Neuromodulation Device Sales Growth Rate (2015-2020) (K Units)
Figure 55. Italy Neurostimulation and Neuromodulation Device Revenue Growth Rate (201
  • Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
    Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118
    The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......
  • Global Non-imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95
    The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Imaging Diagnostic Catheter Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90
    The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
  • Global PCR Equipment Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77
    The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......
  • Global Disposable Sterile Syringes and Needles Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109
    The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......
  • Global Orthopaedic Power Tools Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
  • Global Cerebrospinal Fluid Management Devices Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
  • Global CAD & CAM Milling Burs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
  • Global Artificial Teeth Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98
    The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs